annual cash & cash equivalents:
$482.18M+$225.63M(+87.95%)Summary
- As of today (September 15, 2025), CNTA annual cash & cash equivalents is $482.18 million, with the most recent change of +$225.63 million (+87.95%) on December 31, 2024.
- During the last 3 years, CNTA annual cash & cash equivalents has fallen by -$112.91 million (-18.97%).
- CNTA annual cash & cash equivalents is now -18.97% below its all-time high of $595.08 million, reached on December 31, 2021.
Performance
CNTA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$250.72M-$33.78M(-11.87%)Summary
- As of today (September 15, 2025), CNTA quarterly cash & cash equivalents is $250.72 million, with the most recent change of -$33.78 million (-11.87%) on June 1, 2025.
- Over the past year, CNTA quarterly cash & cash equivalents has dropped by -$44.11 million (-14.96%).
- CNTA quarterly cash & cash equivalents is now -59.15% below its all-time high of $613.76 million, reached on June 30, 2021.
Performance
CNTA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CNTA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +88.0% | -15.0% |
| 3 y3 years | -19.0% | -48.2% |
| 5 y5 years | - | - |
CNTA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.0% | +88.0% | -51.6% | +8.9% |
| 5 y | 5-year | -19.0% | +9537.8% | -59.1% | +8.9% |
| alltime | all time | -19.0% | >+9999.0% | -59.1% | +8.9% |
CNTA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $250.72M(-11.9%) |
| Mar 2025 | - | $284.50M(-41.0%) |
| Dec 2024 | $482.18M(+87.9%) | $482.18M(-7.0%) |
| Sep 2024 | - | $518.45M(+75.8%) |
| Jun 2024 | - | $294.83M(+28.1%) |
| Mar 2024 | - | $230.18M(-10.3%) |
| Dec 2023 | $256.55M(-34.8%) | $256.55M(-8.8%) |
| Sep 2023 | - | $281.34M(-7.3%) |
| Jun 2023 | - | $303.59M(-12.3%) |
| Mar 2023 | - | $346.23M(-12.0%) |
| Dec 2022 | $393.64M | $393.64M(-11.5%) |
| Sep 2022 | - | $444.84M(-8.1%) |
| Jun 2022 | - | $484.16M(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $544.47M(-8.5%) |
| Dec 2021 | $595.08M(>+9900.0%) | $595.08M(+2.8%) |
| Sep 2021 | - | $578.82M(-5.7%) |
| Jun 2021 | - | $613.76M(+105.5%) |
| Mar 2021 | - | $298.61M |
| Dec 2020 | $5.00M(-57.4%) | - |
| Jun 2020 | $11.73M(+79.2%) | - |
| Jun 2019 | $6.55M(-57.9%) | - |
| Jun 2018 | $15.56M(+147.2%) | - |
| Jun 2017 | $6.29M(+89.3%) | - |
| Jun 2016 | $3.32M(-31.5%) | - |
| Jun 2015 | $4.85M(>+9900.0%) | - |
| May 2015 | $400.00(-99.3%) | - |
| May 2014 | $55.30K | - |
FAQ
- What is Centessa Pharmaceuticals plc annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual cash & cash equivalents year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly cash & cash equivalents year-on-year change?
What is Centessa Pharmaceuticals plc annual cash & cash equivalents?
The current annual cash & cash equivalents of CNTA is $482.18M
What is the all time high annual cash & cash equivalents for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual cash & cash equivalents is $595.08M
What is Centessa Pharmaceuticals plc annual cash & cash equivalents year-on-year change?
Over the past year, CNTA annual cash & cash equivalents has changed by +$225.63M (+87.95%)
What is Centessa Pharmaceuticals plc quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CNTA is $250.72M
What is the all time high quarterly cash & cash equivalents for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly cash & cash equivalents is $613.76M
What is Centessa Pharmaceuticals plc quarterly cash & cash equivalents year-on-year change?
Over the past year, CNTA quarterly cash & cash equivalents has changed by -$44.11M (-14.96%)